Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China’s Ministry Of Health Expands Immunization Program

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - China's Ministry of Health has expanded the country's national immunization program to include more vaccines, according to a March 24 notice jointly released by the MOH, Ministry of Finance, National Development and Reform Commission, Ministry of Education and China's State FDA

You may also be interested in...



China’s Health System Reforms Set To Spark Hospital Construction Boom And Boost Medical Device Makers

[Editor's note: This is part two in a new series on China's wide-ranging plans to reform the country's health system, including its hospitals, insurance schemes and access to medicines. Part one appeared in PharmAsia News on Oct. 30, 2008.]

China’s Health System Reforms Set To Spark Hospital Construction Boom And Boost Medical Device Makers

[Editor's note: This is part two in a new series on China's wide-ranging plans to reform the country's health system, including its hospitals, insurance schemes and access to medicines. Part one appeared in PharmAsia News on Oct. 30, 2008.]

China To Expand Vaccine Program

China's Ministry of Health has introduced its expanded immunity program which includes inoculating children against hepatitis A, epidemic encephalitis, epidemic encephalitis B, and measles-mumps-rubella (MMR). Free vaccines to prevent 15 infectious diseases will be provided. Most industry players believe that the domestic vaccine market may double thanks to the program. Beijing Tiantan Biological Products, the only listed local vaccine enterprise, reveals that it plans to build a new plant in Beijing to increase vaccine output in two years. In contrast, international pharmaceutical giants show little activitiy in the field: Sanofi-Aventis and AstraZeneca say they have no relevant vaccines made in China but will keep an eye on the market. (Click here for more - Chinese Language)

UsernamePublicRestriction

Register

MT142578

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel